Echoiq Ltd
EIQ · AU · Healthcare / Health Information Services
0.495AUD-0.03 (-4.81%)
Price History
Full chartMarket Stats
Previous Close0.52
Open0.51
Day Range0.495 – 0.525
52-Week Range0.17 – 1.88
Volume1.67M
Market Cap429.71M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.03
Dividend Yield0.00%
Beta0.14
50-Day Avg1.13
200-Day Avg0.963
About
Echo IQ Limited, an artificial intelligence (AI) and medical technology company, engages in the development and application of AI for the cardiac diagnostics sector in Australia. It offers EchoSolv, a machine-learning and AI-based clinical decision support software for use as an adjunct to echocardiography in the assessment of severe aortic stenosis and other cardiovascular conditions. The company has a research collaboration with Mayo Clinic to assess cardiac risk in patients receiving cancer therapy. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is headquartered in Sydney, Australia.
Company Details
- SectorHealthcare
- IndustryHealth Information Services
- CEOMr. Dustin Haines
- Employees0
- Headquarters66 Clarence Street, Sydney, NSW, Australia, 2000, Australia
- Websitehttps://www.echoiq.ai
Leadership
- Mr. Andrew Richard GroverExecutive Chairman
- Mr. Dustin HainesChief Executive Officer
- Mr. Matthew Joseph Dodds IIIChief Financial Officer
- Mr. Patrick O'SheaHead of Strategy & Operations
- Mr. Sam DribinChief Technology Officer
- Prof. David PlayfordChief Medical Advisor
- Mr. Deon StrydomChief Commercial Officer
- Prof. Geoffrey A. StrangeChief Research & Strategy Officer
- Mr. Dane BrescacinSVP of Regulatory Affairs
- Ms. Jessamyn Sarah Lyons AGIA, B.Com.Company Secretary & Director
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap429.71M
Enterprise Value968.39M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4670.73
Price / Book56.72
EPS-0.03
Book Value0.018
Revenue (TTM)92.00K
Gross Profit (TTM)-6.02M
EBITDA-18.58M
Profit Margin0.00%
Operating Margin-921886.80%
Return on Equity-107.99%
Return on Assets-63.62%
Shares Outstanding740.87M
Shares Float563.66M
Beta0.14
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%
Stock Splits
- Aug 13, 20191:10
- Dec 10, 2015240:227